Introduction
The MedTech industry is in the early stages of three overlapping innovation cycles that are fundamentally changing how devices are designed, sold, and valued. For healthcare bankers, these innovation trends drive M&A activity, create new categories of acquisition targets, and reshape the valuation framework for device companies.
Surgical Robotics
Intuitive Surgical dominated surgical robotics for over two decades with its da Vinci platform. That monopoly is ending as multiple large-cap MedTech companies enter the market:
| Platform | Company | Status | Target Procedures |
|---|---|---|---|
| da Vinci 5 | Intuitive Surgical | Commercial (2024 launch) | Multi-specialty (urology, gynecology, general surgery) |
| Hugo RAS | Medtronic | Limited commercial launch | Soft tissue surgery |
| Ottava | J&J MedTech | Development/early clinical | General surgery |
| Ion | Intuitive Surgical | Commercial | Lung biopsy (flexible robotics) |
| ROSA | Zimmer Biomet | Commercial | Orthopedic (knee, spine) |
| Mako | Stryker | Commercial | Orthopedic (knee, hip) |
Digital Health and Connected Devices
Connected devices generate continuous data streams that enable remote patient monitoring, predictive analytics, and population health management. Examples range from implantable cardiac monitors that transmit arrhythmia data to physician dashboards, to wearable glucose monitors that share readings with endocrinologists in real time.
- Remote Patient Monitoring (RPM)
The use of connected medical devices to collect patient health data outside of traditional clinical settings and transmit it to healthcare providers for assessment. RPM has dedicated CPT reimbursement codes (99453, 99454, 99457, 99458) that allow providers to bill for device setup, data transmission, and clinical review time. This reimbursement pathway has created a new revenue model for MedTech companies: selling connected devices that generate ongoing RPM billing revenue for the provider, aligning provider economics with device adoption.
The digital health layer creates new business model opportunities for traditional MedTech companies. Instead of selling a device and ending the customer relationship at point of sale, connected devices enable ongoing software subscriptions, data analytics services, and clinical decision support tools with software-like margins.
The Big Tech Threat
Apple (Apple Watch ECG, blood oxygen), Google (Fitbit health monitoring, Verily life sciences), and Amazon (Amazon Pharmacy, One Medical acquisition) are all expanding into healthcare-adjacent spaces. While none have yet disrupted core MedTech markets, their consumer reach, data capabilities, and software engineering talent represent a long-term competitive consideration.
The next article covers how devices get sold, including the role of physicians, GPOs, and hospital purchasing dynamics.
Free Interview PDF Guide